DCF vs DDM vs comparables: which valuation method should you use?

Why there is no single right method

Valuation is not physics. There is no formula that spits out the correct price of a business. Each method is a way of asking a different question: what are the cash flows worth? what does the market pay for similar companies? what do M&A buyers actually pay? what are future dividends worth?

Experienced analysts run multiple methods and triangulate. If a DCF gives you £900m, comps give £850–1,000m, and precedent transactions give £950–1,100m, that is useful — it says your intrinsic estimate is roughly consistent with market evidence. If the DCF gives £600m and comps give £1,100m, that gap demands investigation: is the DCF too conservative, or is the market overvaluing the sector?

The four main methods at a glance

DCF: the theoretically correct method

A Discounted Cash Flow model projects a company's free cash flows over an explicit forecast period (typically 5–10 years) and discounts them back to the present at WACC. It then adds a terminal value — which usually represents 60–80% of the total enterprise value — to capture everything beyond the forecast horizon.

When to use it: DCF is best for companies with reasonably predictable operating cash flows — industrials, utilities, mature consumer brands. It is also the right framework for capital allocation decisions (should we invest in this project?) and for situations where no good comparables exist.

Its weakness: DCF output is highly sensitive to two assumptions that are almost impossible to get right precisely: the terminal growth rate and the discount rate (WACC). Small changes in either produce very large swings in enterprise value. A DCF is therefore often described as "garbage in, garbage out" — the model is only as good as its assumptions.

DDM: the dividend specialist

The Dividend Discount Model values a company by discounting expected future dividends at the cost of equity. In its simplest form (Gordon Growth Model), it reduces to: Value = D₁ / (Ke − g), where D₁ is the next dividend, Ke is the cost of equity, and g is the perpetual dividend growth rate.

When to use it: DDM is most useful for mature, dividend-paying companies where dividends are stable and well-covered — traditional utilities, large-cap consumer staples, banks (where dividends are the most direct measure of distributable cash flow, since free cash flow is difficult to define for financial institutions). Equity research analysts covering European banks and utilities use DDM routinely.

Its weakness: DDM breaks down for companies that pay no dividend, repurchase shares instead, or have variable payout policies. It is also highly sensitive to the assumed dividend growth rate — the same sensitivity problem as DCF terminal values.

Comparable company analysis: what the market thinks

Comps takes the market multiples (EV/EBITDA, EV/Revenue, P/E) of comparable listed companies and applies them to the target's own metrics to derive an implied value. If peers trade at 8× EV/EBITDA and the target's EBITDA is £100m, the implied EV is £800m.

When to use it: Almost always — as a primary method for IPO pricing, as a market sanity check on a DCF, and as the primary tool when intrinsic cash flow projections are too uncertain (early-stage companies with high revenue multiples). Comps is the most widely used method in sell-side equity research.

Its weakness: Comps values the company relative to the current market, not on fundamentals. If the whole sector is overvalued (as tech was in 2000 or 2021), comps will tell you the company is worth a lot — even if the fundamentals do not support it. Comps is also only as good as the peer group; a bad peer selection produces a meaningless range.

Precedent transactions: what buyers actually pay

Precedent transactions look at multiples paid in completed M&A deals for comparable companies. Unlike comps, they include a control premium — typically 25–35% above the pre-announcement market price — because an acquirer must pay extra to buy control. This makes deal multiples structurally higher than trading multiples.

When to use it: Essential for M&A mandates — sell-side advisors use precedents to defend the reasonableness of a deal price to boards. Also used in fairness opinions, LBO modelling (to benchmark the entry multiple against historical deal pricing), and restructuring scenarios.

Its weakness: The deal database is often thin and the transactions may be stale — a deal from 2019 may reflect a very different market environment than today. Deal multiples can also be inflated by competitive auction dynamics, strategic synergies the acquirer expected, or simply overpayment.

The football field: using all methods together

In practice, investment banks present all applicable methods in a "football field" — a horizontal bar chart showing the valuation range produced by each method. The overlap between methods gives the most supportable value range; outliers on one method require explanation.

A typical football field might look like:

The DCF and comps overlap at £820–980m — that is where the evidence converges and where an analyst would anchor the valuation. Precedent transactions are higher (reflecting the control premium), which is appropriate if a takeover is the context.

Choosing the primary method

There is no universal answer, but some guidelines help:

• Stable cash flow business (industrials, utilities): DCF primary, comps as cross-check
• Bank or insurer: DDM primary (free cash flow is not meaningful for financial institutions)
• High-growth, pre-profit company: Revenue multiple from comps primary; DCF on long-range terminal value only
• M&A context: Precedent transactions primary or co-primary; comps as market sanity check; DCF for synergy valuation
• LBO: IRR-based model primary (returns-focused), entry multiple benchmarked against precedents